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A large fraction of the human genome encodes intrinsically disordered proteins/regions
(IDPs/IDRs) that are involved in diverse cellular functions/regulation and dysfunctions.
Moreover, several neurodegenerative disorders are associated with the pathological
self-assembly of neuronal IDPs, including tau [Alzheimer’s disease (AD)], α-synuclein
[Parkinson’s disease (PD)], and huntingtin exon 1 [Huntington’s disease (HD)]. Therefore,
there is an urgent and emerging clinical interest in understanding the physical and
structural features of their functional and disease states. However, their biophysical
characterization is inherently challenging by traditional ensemble techniques. First, unlike
globular proteins, IDPs lack stable secondary/tertiary structures under physiological
conditions and may interact with multiple and distinct biological partners, subsequently
folding differentially, thus contributing to the conformational polymorphism. Second,
amyloidogenic IDPs display a high aggregation propensity, undergoing complex
heterogeneous self-assembly mechanisms. In this review article, we discuss the
advantages of employing cutting-edge single-molecule fluorescence (SMF) techniques
to characterize the conformational ensemble of three selected neuronal IDPs (huntingtin
exon 1, tau, and α-synuclein). Specifically, we survey the versatility of these powerful
approaches to describe their monomeric conformational ensemble under functional
and aggregation-prone conditions, and binding to biological partners. Together, the
information gained from these studies provides unique insights into the role of gain or
loss of function of these disordered proteins in neurodegeneration, which may assist
the development of new therapeutic molecules to prevent and treat these devastating
human disorders.
Keywords: intrinsically disordered proteins, neurodegenerative diseases, single-molecule FRET, fluorescence
correlation spectroscopy, huntingtin exon 1, tau, α-synuclein
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INTRODUCTION
The classical protein ‘‘structure–function’’ paradigm establishes
that proteins fold into a unique ordered 3D structure determined
by their amino acid sequence before acquiring a specific
biological function (reviewed in Fersht, 2008). However, studies
over the last two decades have identified functional proteins
lacking a stable secondary and/or tertiary structure, and instead
adopting a dynamic ensemble of multiple conformational
states (Kriwacki et al., 1996; Wright and Dyson, 1999; Mittag
et al., 2010; Babu et al., 2012; Tompa, 2012; van der Lee
et al., 2014). These intrinsically disordered proteins and
regions (IDPs and IDRs, respectively) are widespread in the
human proteome and play critical roles in diverse biological
processes, including in transcription and translation, cell
cycle, signaling, and transport (Iakoucheva et al., 2002;
Wright and Dyson, 2015; Babu, 2016; Tsafou et al., 2018).
Their functional diversity is sustained by unique features:
(i) quick response to variations in cellular environment;
(ii) interaction with multiple binding partners (with high
specificity but low affinity) that provides binding promiscuity;
and (iii) tight regulation by posttranslational modifications
(PTMs) (Babu et al., 2012; Uversky, 2015; Babu, 2016). The
misbehavior and misfolding of these naturally flexible proteins
or regions can ultimately lead to their dysfunction. Therefore,
IDPs/IDRs have been implicated in several devastating
human diseases (such as in neurodegeneration and cancer),
supporting the emerging ‘‘disorder in disorders’’ (or D2) concept
(Uversky et al., 2008).
Many severe neurodegenerative disorders are associated
with the pathological self-assembly and extra- or intracellular
deposition of neuronal IDPs or proteins containing IDRs. These
include amyloid-β (Aβ) peptides in Alzheimer’s disease (AD);
tau in multiple tauopathies (including AD); α-synuclein (αS)
in Parkinson’s disease (PD); huntingtin (HTT) in Huntington’s
disease (HD); and TAR DNA-binding protein-43 (TDP-43) and
fused in sarcoma (FUS) protein in amyotrophic lateral sclerosis
and frontotemporal lobar degeneration (FTLD; reviewed in
Uversky, 2014, 2015). These neurodegeneration-promoting
proteins are fully or locally disordered in their monomeric-
unbound state, but surprisingly they display a high tendency
to form ordered insoluble aggregates (Uversky, 2014). In
addition, accumulated evidence supports that aggregation-prone
IDPs/IDRs can cause neurodegeneration through the failure to
adopt a functional state (loss of their native functions) and/or
gain of abnormal toxic interactions or protein accumulation
resulting in toxic oligomers/aggregates (toxic gain of function;
Trojanowski and Lee, 2005; Winklhofer et al., 2008). Effective
therapies should be designed to restore their biological functions
and/or avoid their aggregation at early stages. Therefore,
there is an urgent medical interest in understanding these
neuronal IDPs/IDRs in normal and disease conditions by:
(i) characterizing their functional diversity and structural
rearrangements upon interaction with distinct binding partners;
and (ii) determining the conformational ensemble of their
monomers under conditions that favor aggregation, which are
ideal clinical targets. Together, these approaches will provide
insights into the key physical and structural features of these
aggregation-prone IDPs/IDRs that trigger gain or loss of
function, and ultimately cause neuronal cell death.
Remarkably, single-molecule fluorescence (SMF) methods
have enhanced our understanding of IDPs, including amyloid-
forming proteins, during the past two decades (reviewed in
Brucale et al., 2014; Schuler et al., 2016). Numerous SMF
methodologies have been developed for probing transient
oligomeric species and to determine their stoichiometry. These
include two-color coincidence detection (TCCD; Cremades
et al., 2012), single-molecule Förster resonance energy transfer
(smFRET; Shammas et al., 2015), total internal reflection
fluorescence microscopy (TIRF)-based approaches (Lv et al.,
2015), or single-molecule photobleaching (Zijlstra et al., 2012).
In addition, SMF techniques have been successfully used to
characterize the complex conformational distribution and
plasticity of monomeric IDPs, and molecular interactions
with biological partners or aggregation inducers (Banerjee
and Deniz, 2014; Lee et al., 2015). While the application
of SMF approaches to uncover oligomeric states has
been largely debated (Kundel et al., 2018), in this review
article, we focus on the use of SMF methods to study the
conformational ensemble of monomeric neurodegeneration-
promoting IDPs under functional and aggregation-prone
conditions. Notably, the low protein concentrations required
for these techniques (in the pM or nM range) inhibit
the rapid protein self-assembly. In addition, recording
behaviors of individual molecules enables the description
of dynamic/heterogeneous systems and the detection of
coexisting subpopulations, which are not accessible in traditional
ensemble and time-averaging methodologies (Figure 1; Joo
et al., 2008; Schuler and Eaton, 2008; Schuler et al., 2016).
From this class of SMF methods, fluorescence correlation
spectroscopy (FCS) and smFRET have emerged as powerful and
versatile tools.
FCS measures fluorescence-intensity fluctuations arising
from the diffusion of a few fluorescent molecules through a
small confocal observation volume (∼1 fL). These fluorescence
fluctuations are then analyzed using the autocorrelation
function that quantifies the self-similarity of the signal over
several delay times. Commonly, it can provide information in
local concentrations, molecular mobility, and/or photophysical
properties (Hess et al., 2002). Moreover, FCS allows to determine
the overall chain dimensions of proteins (for homogeneous
populations) and molecular interactions using the translational
diffusion time at a slow time scale and conformational dynamics
at fast time scales (Chattopadhyay et al., 2005; Sherman et al.,
2008; Melo et al., 2011). In particular, nanosecond FCS in
conjugation with smFRET and polymer physics can be used to
quantify the reconfiguration time of unfolded polypeptide chains
(Soranno et al., 2012). Therefore, FCS has been widely applied
to evaluate the hydrodynamic size of monomeric IDPs, internal
conformational dynamics, and molecular interactions (Figure 1;
Crick et al., 2006; Rhoades et al., 2006; Middleton and Rhoades,
2010; Li et al., 2015; Li and Rhoades, 2017).
In addition, smFRET relies on the non-radiative energy
transfer from a donor fluorophore to an acceptor fluorophore
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FIGURE 1 | Untangling the conformational heterogeneity and molecular
interactions of monomeric intrinsically disordered proteins (IDPs) through
single-molecule fluorescence (SMF) approaches. Single-molecule Förster
resonance energy transfer (smFRET) histogram discriminating between
distinct conformational ensembles of double-label protein (donor–acceptor):
monomeric free protein in solution and bound states with extended (low ETeff)
or compacted conformations (high ETeff). Fluorescence correlation
spectroscopy (FCS) autocorrelation curve reporting on changes in the
diffusion time of single-label protein free in solution (blue curve) and upon
interaction with aggregation inducers or binding partners (gray curve). The
binding results into a shift of the autocorrelation curve to the right (longer
translational diffusion times).
through a dipole–dipole coupling mechanism. The efficiency of
transfer (ETeff) exhibits an inverse sixth power dependence on
the interdye distance, allowing to determine distances on the
nanometer scale (∼2–10 nm, as a ‘‘spectroscopic ruler’’; Forster,
1949). Therefore, intramolecular smFRET (both donor and
acceptor fluorophores located on same molecule) can evaluate
conformational rearrangements and dynamics of proteins (Chen
and Rhoades, 2008; Banerjee and Deniz, 2014; Schuler et al.,
2016). Several strategies have been applied for site-specific
double-labeling IDPs, including the use of cysteine residues
and genetically encoded unnatural amino acids (Lemke, 2011).
Briefly, in diffusion-based smFRET, fluorescence intensities
are recorded for each donor–acceptor labeled protein while it
diffuses across a small confocal volume, and subsequently ETeff
values are calculated for each photon burst and plotted as a
histogram (Brucale et al., 2014; Schuler et al., 2016). Due to
the high structural heterogeneity of IDPs, the Förster equation
cannot provide a precise conversion of mean ETeff values into
distances (O’Brien et al., 2009), since there is a wide distribution
of donor–acceptor distances (without a single fixed distance).
Commonly, several polymer models have been employed to
describe the conformational ensemble of IDPs and denatured
proteins. These include the Gaussian chain, worm-like chain, or
a weighted Flory-Fisk distribution (discussed in detail in Schuler
et al., 2016). Remarkably, intramolecular smFRET can report
on conformational changes and dynamics of neurodegeneration-
promoting IDPs in solution and upon binding to functional
partners or aggregation promoters (Figure 1; Ferreon et al.,
2009; Trexler and Rhoades, 2009, 2010; Elbaum-Garfinkle and
Rhoades, 2012; Melo et al., 2016, 2017).
In this short review, we focus on the IDPs—huntingtin exon
1 (HTTex1), tau, and αS—and discuss a series of key SFM
studies to characterize their heterogeneous/dynamic monomeric
conformational ensemble and also interactions relevant for their
function or disease.
HTTex1 IN HD
HTT is a large multidomain protein (with over 3,000 amino
acids and 348 kDa) that is involved in several complex cellular
processes, such as in trafficking of vesicles and organelles,
transcription regulation, and generally in cellular homeostasis
(reviewed in Schulte and Littleton, 2011; Saudou and Humbert,
2016). HTT is of major clinical relevance because the abnormal
expansion of the CAG repeat within the first exon of its gene
(IT15) is the pathological hallmark of HD (MacDonald et al.,
1993). Above a critical threshold of about 37 CAG repeats,
it leads to the expression of a mutant HTT protein with
an expanded polyglutamine (polyQ) domain, which ultimately
forms amyloid-like fibrils and intracellular inclusion bodies
(Bates et al., 2014). The aberrant splicing and proteolytic
cleavage of mutant proteins result in highly toxic HTT
fragments spanning exon 1 (HTTex1; Wellington et al., 2002;
Sathasivam et al., 2013), which are sufficient to replicate
much of HD’s pathology/progression (Mangiarini et al., 1996).
The exact molecular mechanism whereby HTTex1 contributes
to neurodegeneration remains elusive, but growing evidence
supports that the molecular sources of neurotoxicity inherent
to the polyQ expansion are toxic conformations of the
monomer and/or oligomers (Nagai et al., 2007; Takahashi
et al., 2008). Therefore, considerable effort has been devoted to
characterize the conformational features of monomeric polyQ
peptides and HTTex1 in solution (reviewed in Wetzel, 2012;
Adegbuyiro et al., 2017).
HTTex1 consists of a polyQ domain flanked by an
N-terminal 17 amino acid segment (N17) and a C-terminal
proline-rich region (PRR; Wetzel, 2012; Adegbuyiro et al.,
2017). Since the age of onset, risk of disease and severity
in HD are strongly correlated with the polyQ length (Bates
et al., 2014), the early structural studies solely focused on
simple synthetic polyQ peptides (with extra lysine residues
to improve their solubility). Several circular dichroism (CD)
and nuclear magnetic resonance (NMR) studies have shown
that simple polyQ sequences regardless of their repeat length
are predominantly disordered in solution (Altschuler et al.,
1997; Chen et al., 2001; Klein et al., 2007). In a pioneering
FCS study, Crick et al. (2006) identified the hydrodynamic
radius of monomeric polyQ peptides to obtain insights into
their global dimensions and also shapes. The authors measured
the average translational diffusion time (proportional to the
hydrodynamic radius) of (Gly)-(Gln)N-Cys-Lys2 peptides in
solution and assessed how it scales with the chain length.
Notably, FCS revealed that: (i) aqueous solution is a ‘‘poor
solvent’’ (low scaling exponent with v = 0.32 ± 0.02), suggesting
that monomeric polyQ sequences adopt a heterogeneous
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ensemble of collapsed conformations; and (ii) the absence of
sharp structural transitions across the critical polyQ length
(no drastic changes in the diffusion time with increasing
chain lengths).
A detailed understanding of the structural basis of monomeric
mutant HTTex1 is crucial for developing a mechanistic model
for HTTex1 toxicity. Current hypotheses describing the
toxic structural threshold are largely sustained by indirect
evidences. In particular, numerous studies over the last
decade support that both flanking regions (PRR and N17)
strongly modulate the aggregation of HTTex1 in solution
(Thakur et al., 2009; Crick et al., 2013; Shen et al., 2016)
and in the presence of biological membranes (Burke et al.,
2013). Specifically, in solution, N17 enhances aggregation in a
distinct mechanism to that of synthetic polyQ peptides (Thakur
et al., 2009), while PRR displays an opposite effect, favoring
aggregation-resistant conformations (Bhattacharyya et al., 2006).
Together, it supports that the cross-talk between both flanking
regions and/or a sharp conformational transition above the
pathological polyQ threshold control the HTTex1 cytotoxicity.
Nevertheless, there remains controversy due to the absence
of single-atom resolution structures of HTTex1 (ones lacking
solubilizing tags or stabilizing amino acids). This is due to
the high aggregation propensity of HTTex1, the disordered
features of the polyQ stretches, and the inherent challenge
of recombinant expression and purification of HTTex1.
While a recent high-resolution cryo-electron microscopy
structure for the full-length HTT protein was reported in a
complex with HTT-associated protein 40 (HAP40), the exon
1 region was not solved due to its disordered nature (Guo
et al., 2018). Notably, the first single-molecule structural
characterization of monomeric HTTex1 in solution was
recently provided by a collaborative study from the Lemke,
Pappu, and Lashuel groups (Warner et al., 2017). In this
elegant study, smFRET was used to determine intramolecular
distances within monomeric HTTex1 at pM concentrations,
where its self-assembly and phase separation are prevented.
Briefly, both an intein-fusion strategy and a semi-synthetic
approach were employed to create five polyQ lengths
HTTex1 variants (15Q, 23Q, 37Q, 43Q, and 49Q). For each
variant, multiple double-labeled smFRET constructs were
designed by site-specific labeling at a fixed position in N17
(A2C with Alexa 488 maleimide dye) and variable in PRR
(A60C, P70C, P80C, or P90C with Alexa 594 maleimide dye).
Remarkably, using smFRET in combination with atomistic
simulations, Warner and co-workers proposed that both
wild-type (WT) and mutant HTTex1 adopt a ‘‘tadpole-
like’’ topology, in which N17 adsorbs on the polyQ tract,
making a ‘‘globular head,’’ and the PRR domain forms
an extended/semi-flexible chain. Therefore, contrary to
previous indirect evidences, smFRET data argue against
sharp structural transitions in HTTex1 at pathological polyQ
lengths in solution. The authors suggested that the increase
of the polyQ surface area with its length promotes: (i) toxic
‘‘heterotypic interactions’’ by increasing the binding sites;
and (ii) ‘‘homotypic interactions’’ that ultimately trigger
HTTex1 aggregation.
In light of this recent smFRET work, future studies should
firstly evaluate whether the toxic polyQ expansion controls
the HTTex1 interactome. In particular, FCS or fluorescence
cross-correlation spectroscopy (FCCS) will allow to quantify
the interaction of WT (as control) and mutant HTTex1 with:
(i) biological partners or emerging interacting proteins; (ii)
biological membranes with variable lipid composition; and (iii)
molecular chaperones. Simultaneously, the characterization of
the conformational ensemble of HTTex1 under functional and
aggregation-prone conditions through smFRET will provide
insights into toxicity relevant conformations.
TAU IN TAUOPATHIES
Tau is a microtubule-associated protein (MAP) found
predominantly in the axons of neurons (Litman et al., 1993;
Hirokawa et al., 1996) that plays a critical role in microtubule
(MT) assembly/stabilization (Weingarten et al., 1975; Drubin
and Kirschner, 1986; Gustke et al., 1994; Trinczek et al., 1995;
Goode et al., 2000) and axonal transport (Ebneth et al., 1998;
Terwel et al., 2002). Its pathological aggregation and deposition
are associated with numerous devastating neurodegenerative
disorders termed tauopathies, including AD, FTLD, chronic
traumatic encephalopathy, and Pick’s disease (reviewed in
Brunden et al., 2009). Accumulating evidence supports that the
disruption of its native function as a MAP can also contribute
to these tauopathies (Ballatore et al., 2007; Winklhofer et al.,
2008). For instance, the abnormal hyperphosphorylation of tau
can promote its self-assembly into toxic oligomers and paired
helical filaments (PHFs), as well as reduces tau–MT interaction,
resulting in MT destabilization and cell death (reviewed in
Johnson and Stoothoff, 2004).
Tau consists of three major functional regions: (1) MT
binding region (MTBR) composed of imperfect repeats that
directly interacts withMTs/tubulin (Butner and Kirschner, 1991)
and forms the core of PHFs (Crowther et al., 1989); (2) a
proline-rich domain (PRD) that increases MT-binding/assembly
(Gustke et al., 1994); and finally (3) an N-terminal projection
domain that controls MT spacing (Chen et al., 1992) and might
bind to neuronal plasmamembrane (Brandt et al., 1995). In adult
human brains, the alternative splicing of a single MAPT gene
results in six different isoforms (ranging from 352 to 441 amino
acids) that contain up to twoN-terminal inserts (0N, 1N, and 2N)
and three or four imperfect repeats (3R or 4R) within MTBR.
Tau is a large disordered protein in its monomeric unbound
state (Cleveland et al., 1977). The full-length protein is
highly demanding for NMR (Mukrasch et al., 2009), and so
far, most NMR studies have used MTBR fragments. In a
seminal ensemble FRET study, Mandelkow and co-workers
identified that tau forms a highly compact structure in
solution described by a ‘‘paperclip’’ conformation (Jeganathan
et al., 2006). Specifically, this early work revealed that the
C-terminus is in close proximity to the N-terminus and the
MTBR, but without a measured FRET distance (so higher than
10 nm) between the N-terminus and the MTBR. Recently,
the Rhoades Lab used SMF methods to characterize the
aggregation-prone structures of tau [in the presence of heparin
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(Elbaum-Garfinkle and Rhoades, 2012) and polyphosphates
(polyP; Wickramasinghe et al., 2019)] and the functional
conformations [with soluble tubulin heterodimers (Elbaum-
Garfinkle et al., 2014; Li et al., 2015; Melo et al., 2016)]. Below,
we summarize the studies reporting on the conformational
transitions undergone by tau relevant to its functional and
aggregation-prone states.
Initial smFRET work by Elbaum-Garfinkle and Rhoades
redefined the ‘‘paperclip’’ model from ensemble measurements
for tau monomer in solution and also characterized its
conformational ensemble in the presence of heparin (Elbaum-
Garfinkle and Rhoades, 2012). This comprehensive work
investigated 12 double-labeled constructs of tau that mapped
multiple overlapping regions within the 2N4R isoform (longest
tau isoform), and their respective ETeff were reported for
each construct in the absence and presence of heparin.
In solution, the overall dimensions of tau diverge from a
theoretical random coil protein in a ‘‘good solvent.’’ This
is further sustained by intramolecular contacts between the
N- and C-termini and also each terminus and the MTBR,
which was ascribed to electrostatic effects. Together, smFRET
data supported that tau adopts more an ‘‘S-shaped’’ than a
‘‘paperclip’’ topology (Jeganathan et al., 2006; from ensemble
FRET) in solution, since the MTBR is in relatively close
contact with both termini. The discrepancy is explained,
in part, by the use of: (i) a donor–acceptor pair with a
small Förster radius; and (ii) the Förster equation to directly
convert ETeff into distances, in ensemble measurements.
Notably, the same work also revealed that tau undergoes a
two-state conformational transition upon binding to heparin
underlined by the pronounced MTBR compaction and the
loss of the long-range interactions between the two termini.
Moreover, different domains of tau exhibit distinct physical and
structural features, and consequently they respond differentially
upon heparin binding. In a recent study, Wickramasinghe
and co-workers investigated the interaction of tau with the
physiologically aggregation inducer, polyP, using FCS and
smFRET (Wickramasinghe et al., 2019). Specifically, following
a similar approach as described for heparin, smFRET data
reported that polyP promotes a local compaction of the MTBR
and PRD, with a concomitant decrease in the long-range
contacts between both termini. The binding of tau to polyP
was further characterized by FCS, revealing that both PRD and
MTBR interact with polyP. The conformational changes and
aggregation effects depicted were found to strongly correlate
with the polyP chain length. Moreover, longer polyP chains
were shown to promote intermolecular interactions in tau
monomers (working as ‘‘intermolecular scaffold’’), thus inducing
its pathological aggregation.
Most research on tau function has been focused so far on
its role in MT dynamic instability and its interaction with
stabilized MTs. In addition, ensemble MT polymerization assays
(based on scatter measurements) do not provide a detailed
description of the first step of MT assembly. Therefore, the
molecular mechanism by which tau promotes the polymerization
of tubulin into MTs remains poorly understood. The Rhoades
Lab has applied SMF methods to describe the largely overlooked
interaction of tau with soluble tubulin heterodimers (the first step
of MT assembly mechanism). In a pioneering work, Elbaum-
Garfinkle et al. (2014) identified for the first time by FCS
that tau binds to soluble tubulin heterodimers (under non MT
assembly conditions, with a low concentration of tau and in a
buffer lacking GTP), and disease mutations also enhance this
interaction. In two subsequent FCS studies, Li et al. (2015) and
Li and Rhoades (2017) showed that: (i) tau binds to multiple
tubulin heterodimers (Li et al., 2015); and (ii) the C-terminal
pseudo-repeat region of tau (adjacent to MTBR) increases the
heterogeneity of tau–tubulin complex with further independent
binding sites at R2 and R3, in which the size and heterogeneity
are strongly linked to tau function (MT polymerization; Li
and Rhoades, 2017). The topological features of tau in this
heterogeneous/dynamic complex were further investigated by
intramolecular smFRET (Melo et al., 2016). These measurements
were performed under 100% tubulin binding and a multiprobe
approach was again employed for 2N4R and 2N3R tau isoforms.
Remarkably, large shifts toward lower mean ETeff were observed
for constructs probing the solution long-range interactions (for
both termini and each terminus and the MTBR). This work
revealed that tau adopts an overall open structure in this
complex, exposing binding sites within the MTBR. Similarly, this
expansion is observed upon binding to the MT surface (Sillen
et al., 2007) and heparin (Elbaum-Garfinkle and Rhoades, 2012).
Surprisingly, smFRET data also showed that theMTBR conserves
its global dimensions, while its individual repeats experience local
extensions to provide binding to multiple tubulin heterodimers.
The extent of conformational changes within the MTBR was
larger for two repeat-spanning constructs for both isoforms, also
including R3. Contrary to NMR data for tau bound to a single-
tubulin dimer (Gigant et al., 2014), no evidence for the U-turn
topology adopted by theMTBRwas found. Finally, these findings
supported that tau forms a ‘‘fuzzy complex’’ with soluble tubulin,
in which it retains its flexibility and conformational plasticity as
an IDP. However, it remains to be elucidated whether tau can
bind simultaneously tubulin and MTs.
In summary, smFRET revealed that the MTBR
responds differentially upon interaction with soluble
tubulin or heparin/polyP that accounts for distinct
conformational ensembles of tau in its tubulin-bound state
and aggregation-prone structure, respectively. In addition,
it provides a framework to explore the role of PTMs (as
hyperphosphorylation) in the conformational ensemble of
monomeric tau under functional (‘‘fuzzy complex’’ with soluble
tubulin) and disease conditions. Finally, as recent studies support
that tau can undergo liquid–liquid phase separation (LLPS;
Hernández-Vega et al., 2017; Zhang et al., 2017; Wegmann
et al., 2018), smFRET provides a versatile tool to probe early
conformational changes that trigger phase separation (in the
presence of molecular crowding and RNA), and to explore the
dynamics within the droplet.
αS IN PD
αS is a small protein (140 amino acids) abundantly expressed
in presynaptic terminals of neurons in the human brain
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(Maroteaux et al., 1988; Jakes et al., 1994). This protein is
intrinsically flexible in solution and, similar to other IDPs,
acquires structure upon binding to biological binding partners
as lipid membranes (Weinreb et al., 1996; Davidson et al., 1998;
Eliezer et al., 2001). While αS has been associated with several
biological activities, including in regulation of synaptic vesicles
pools (Murphy et al., 2000; Cabin et al., 2002), neurotransmitter
release (Nemani et al., 2010), SNARE complex assembly (Burré
et al., 2010), and vesicle trafficking (Cooper et al., 2006; Snead
and Eliezer, 2019), the precise function of this protein remains
enigmatic and controversial. αS is the major component of
intracellular amyloid deposits known as Lewy bodies and has
thus been implicated in the development and pathogenesis of
neurodegenerative disorders, such as PD (Polymeropoulos et al.,
1997; Spillantini et al., 1998; Goedert, 2001). In particular,
biological membranes appear to play a key role in αS function
and dysfunction (reviewed in Snead and Eliezer, 2014).
αS contains three main regions: (1) N-terminal region that
mediates binding to lipid membranes; (2) a central hydrophobic
non-amyloid β-component (NAC) region responsible for its
self-assembly; and (3) a highly negatively charged C-terminus.
Several ensemble biophysical methods, including NMR (Eliezer
et al., 2001; Bussell and Eliezer, 2003; Chandra et al., 2003;
Dedmon et al., 2005), electron paramagnetic resonance (EPR)
spectroscopy (Jao et al., 2004; Drescher et al., 2008), and CD
(Chandra et al., 2003; Ferreon and Deniz, 2007), have provided
valuable insights into the conformational transitions in αS upon
interaction with sodium dodecyl sulfate (SDS) micelles and/or
lipid vesicles. In addition, a recent in-cell NMR study revealed
that the disordered nature of monomeric αS is highly conserved
in the cytoplasm of mammalian cells (Theillet et al., 2016).
A seminal FCS work from the Webb and Eliezer groups
quantified the binding of αS to large unilamellar vesicles (LUVs)
prepared with variable anionic lipid content, showing that
electrostatic effects strongly enhance the αS-lipid interaction
(Rhoades et al., 2006). In a subsequent FCS study from the
Rhoades lab, this interaction was further explored as a function
of different lipid compositions (anionic and saturated lipids),
membrane curvature, and PD-associated mutations (Middleton
and Rhoades, 2010). This work revealed a preferential binding of
αS to gel-phase liposomes when compared to fluid-phase vesicles.
Moreover, it reported on drastic effects of membrane curvature,
underlining a stronger affinity of αS for small unilamellar
vesicles (SUVs) over LUVs. Finally, PD-associated mutations
presented only minor changes in the molar membrane-partition
coefficients compared to the WT protein.
To better understand the disorder-to-order transitions in
αS, several studies have employed SMF methods to identify
and resolve multiple coexisting populations and its structural
heterogeneity. Pioneering smFRET experiments from the Deniz,
Rhoades, and Subramaniam labs provided structural insights
into the conformational switching between the broken and
extended α-helical structures adopted by αS upon binding to
SDS micelles and lipid vesicles (Ferreon et al., 2009; Trexler
and Rhoades, 2009; Veldhuis et al., 2009). These works were
able to distinguish between conflicting reports from ensemble
measurements debating the configuration of micelle or lipid
bound αS (Chandra et al., 2003; Borbat et al., 2006). smFRET
identified a broken α-helical conformation adopted by αS upon
binding to SDS above the critical micelle concentration. Further,
the Deniz and Rhoades labs identified that the binding surface
curvature strongly modulates the helical topology of αS. Their
works revealed that αS adopts an extended helical structure upon
binding to low-curvature SDS or lipid surfaces, while it assumes a
bent-helix conformation on highly curved SDS micelles. Further
work from the Deniz group explored the effect of PD-associated
mutations on αS folding by both CD and smFRETmeasurements
(Ferreon et al., 2010). It revealed that A53T, E46K, and C-
terminal truncation (residues 1–107) variants display a similar
multistate folding behavior to WT protein. However, the A30P
mutation (located on the membrane binding region) was found
to not adopt an extended conformation at SDS concentrations
near or below the critical micelle concentration. A more recent
study from the same lab investigated the ‘‘two-dimensional (2D)
crowding’’ effect on the structural transitions of αS at membrane
surface (Banerjee et al., 2016). Under high ‘‘2D crowding’’
conditions promoted by the simultaneous membrane binding
of αS and Hsp27 (a lipid-interacting chaperone), αS was found
to adopt an alternative (‘‘hidden’’) conformation, which is not
highly populated at chaperone-free conditions.
smFRET work from Trexler and Rhoades also probed the
aggregation-prone structures of αS under different aggregation-
promoting conditions, such as low pH and in the presence
of aggregation inducers (spermine and heparin; Trexler and
Rhoades, 2010). Remarkably, this work revealed that the low
pH and aggregation inducers promote distinct effects on the αS
structure. Briefly, the C-terminus of αS was found to structurally
collapse at low pH, while minor effects were reported on the
N-terminus and the central region of the protein. However,
this local compaction of C-terminal region had no significant
effect on the overall dimensions of αS. Meanwhile, αS binding to
both heparin or spermine showed a lack of large-scale structural
transitions. In addition, recent work from the Deniz lab used a
combination of SMF and ensemble methods to investigate the
effect of osmolytes in αS folding (Moosa et al., 2015). Contrary to
the SDS folding pathway, this study supported that αS follows
a two-state transition in the presence of osmolytes, consisting
of rapid interconverting conformations of unfolded and force-
folded states. The effects obtained for both osmolytes and ‘‘2D
crowding’’ support that complex cellular contexts need to be
explored in order to describe the physiological folding landscape
of αS. On that note, recent work from the Rhoades lab revealed
that cell-surface-exposed glycans are potential cellular interactors
of αS (Birol et al., 2019). This work employed FCS to quantify
the interaction of monomer αS with glycans, and identified these
cell exposed glycans as key modulators of αS internalization
in cells.
Together, these works have identified and described the
conformational landscape of αS under diverse conditions (such
as membrane-bound state, PD-associated mutations, and the
presence of osmolytes and ‘‘2D crowding’’) and provide an
outline in the future to also evaluate the impact of PTMs.
In addition, future in vivo smFRET measurements could
complement in-cell MNR data (although performed at different
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concentration range). In particular, it will allow to determine
the physical/structural features of αS under physiological and
disease situations and to evaluate in vivo conditions promoting
the disorder-to-order transition.
CONCLUSION REMARKS
SMF methods have been recognized as powerful and versatile
approaches to investigate the heterogeneous and dynamic nature
of neurodegeneration-associated IDPs, including HTTex1, tau,
and αS as discussed in this review article. These cutting-edge
techniques have provided valuable insights into: (i) their
monomeric states; (ii) the aggregation-prone structures of
tau and αS; (iii) the disorder-to-order transition of αS upon
membrane binding; and finally (iv) the formation of a ‘‘fuzzy
complex’’ by tau bound to soluble tubulin. However, the
structural interpretation of smFRET data is highly challenging
for IDPs due to their heterogeneous and dynamic nature.
For IDPs systems, Förster equation does not provide a
direct conversation of ETeff in distances, and polymer physics
models have been successfully applied to describe the broad
distribution of donor–acceptor distances. Moreover, smFRET
requires site-specific double-labeling proteins with small organic
dyes through natural/mutated cysteines or genetically encoded
unnatural amino acids. Meanwhile, molecular dynamics (MD)
simulation provides a valuable tool to rationalize smFRET data,
including to describe the dynamic movement of the dye molecule
and to consider its linker, and together to provide insights into
IDP conformational dynamics.
Most SMF research performed for the discussed proteins has
been restricted to in vitro studies. As such, native functional
interactions and the associated conformational changes in
the cellular context are underinvestigated. Therefore, it is
crucial to move SMF methods towards in vivo conditions.
For smFRET, it requires developing new strategies for in vivo
labeling proteins, as fluorescent proteins are not suitable. Recent
advances by Schuler and colleagues used microinjection to
deliver IDPs (recombinant protein labeled in vitro) in live
mammalian cells and employed a range of SMF techniques
(including smFRET) to describe their structural dynamics
(König et al., 2015), providing a new avenue to study this
challenging class of proteins. We anticipate that adapting
a similar approach to the systems discussed in this review
article and future advances in SMF tools and application will
allow to characterize the conformational ensemble of these
neuronal IDPs in vivo, and simultaneously reveal and delineate
toxic structural transitions associated to their loss of function
or aggregation.
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